Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)	Common stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Oct. 11, 2020
Balance (in Shares) at Oct. 11, 2020
Common stock issued to Sponsor	$ 543	24,457		25,000
Common stock issued to Sponsor (in Shares)	5,433,750
Issuance of representative shares	$ 19	851		870
Issuance of representative shares (in Shares)	189,000
Net loss			(2,642)	(2,642)
Balance at Dec. 31, 2020	$ 562	25,308	(2,642)	23,228
Balance (in Shares) at Dec. 31, 2020	5,622,750
Private Placement Shares sold	$ 78	7,699,922		7,700,000
Private Placement Shares sold (in Shares)	770,000
Representative shares issued	$ 15	(15)
Representative shares issued (in Shares)	151,200
Representative shares returned	$ (27)	27
Representative shares returned (in Shares)	(264,600)
Forfeiture of founder shares	$ (1)	1
Forfeiture of founder shares (in Shares)	(8,750)
Proceeds allocated to public warrants		6,062,414		6,062,414
Proceeds allocated to public warrants (in Shares)
Issuance costs allocated to public warrants		(445,147)		(445,147)
Issuance costs allocated to public warrants (in Shares)
Reimbursement of company expenses by the underwriter		543,450		543,450
Reimbursement of company expenses by the underwriter (in Shares)
Remeasurement of common stock subject to possible redemption amount		(13,885,960)	(6,212,554)	(20,098,514)
Net loss			(888,941)	(888,941)
Balance at Dec. 31, 2021	$ 627		$ (7,104,137)	$ (7,103,510)
Balance (in Shares) at Dec. 31, 2021	6,270,600